NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 76 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,706 | -18.3% | 21,426 | 0.0% | 0.00% | – |
| Q2 2023 | $82,919 | +44.2% | 21,426 | +3.2% | 0.00% | – |
| Q1 2023 | $57,489 | +53.9% | 20,754 | 0.0% | 0.00% | – |
| Q4 2022 | $37,357 | -15.1% | 20,754 | 0.0% | 0.00% | – |
| Q3 2022 | $43,998 | -21.4% | 20,754 | 0.0% | 0.00% | – |
| Q2 2022 | $56,000 | – | 20,754 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $30,663,000 | 4.08% |
| Ally Bridge Group (NY) LLC | 1,500,000 | $9,210,000 | 2.71% |
| AMAZON COM INC | 1,457,055 | $8,946,000 | 1.82% |
| Affinity Asset Advisors, LLC | 975,000 | $5,987,000 | 1.51% |
| Tikvah Management LLC | 708,540 | $4,350,436,000 | 1.18% |
| Perceptive Advisors | 8,911,151 | $54,714,000 | 0.80% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $12,280,000 | 0.76% |
| HILLMAN CO | 200,000 | $1,228,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $4,912,000 | 0.41% |
| RA Capital Management | 2,436,430 | $14,960,000 | 0.21% |